Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98174 | 0.86 | CYP17A1 (0.41) | MMP1MMP9MMP8 | |
| Hydrochloric Acid SCHEMBL31108770 | 0.85 | CYP17A1 (0.42) | MMP1MMP9MMP8 | |
| SCHEMBL30029852 | 0.75 | MMP1 (0.35) | MMP1MMP9MMP8 | |
| SCHEMBL13305184 | 0.74 | NPSR1 (0.41) | MMP1MMP9MMP8 | |
| Bromide SCHEMBL30996178 | 0.74 | MMP1 (0.34) | MMP1MMP9MMP8 | |
| SCHEMBL25740714 | 0.73 | NPSR1 (0.30) | OPRM1 | |
| SCHEMBL25689778 | 0.67 | CYP17A1 (0.42) | MMP1MMP9MMP8 | |
| SCHEMBL25595294 | 0.67 | CYP17A1 (0.44) | — | |
| SCHEMBL25468324 | 0.66 | CYP17A1 (0.43) | MMP1MMP9MMP8 | |
| SCHEMBL22821191 | 0.66 | CYP17A1 (0.43) | MMP1MMP9MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120148955-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND NEW COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148955-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND NEW COMPOUND | C1R, SLC11A2, RER1 | MMP1 2707/4885MMP9 3095/4885MMP8 1803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.